BBIO icon

BridgeBio Pharma

181 hedge funds and large institutions have $1.44B invested in BridgeBio Pharma in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 72 increasing their positions, 48 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
181
Holders Change
+17
Holders Change %
+10.37%
% of All Funds
3.13%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
31
Increased
72
Reduced
48
Closed
14
Calls
$4.5M
Puts
$3.19M
Net Calls
+$1.31M
Net Calls Change
-$4.18M
Name Holding Trade Value Shares
Change
Shares
Change %
Group One Trading
176
Group One Trading
Illinois
-$761K -83,858 Closed
AG
177
Algert Global
California
-$349K -38,430 Closed
Walleye Trading
178
Walleye Trading
New York
-$244K -26,896 Closed
PA
179
Profund Advisors
Maryland
-$132K -14,549 Closed
QT
180
Quantamental Technologies
New York
-$112K -12,326 Closed
LPL Financial
181
LPL Financial
California
-$98K -10,832 Closed
Bank of Montreal
182
Bank of Montreal
Ontario, Canada
-$90 -10,001 Closed
PI
183
PEAK6 Investments
Illinois
-$172K -10,000 Closed
PCIG
184
Partners Capital Investment Group
Massachusetts
-$12K -1,371 Closed
CAPTRUST Financial Advisors
185
CAPTRUST Financial Advisors
North Carolina
-$9K -1,034 Closed